Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31
October 24 2022 - 7:00AM
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the
Company will report its fourth quarter and full year fiscal 2022
financial results on Monday, October 31, 2022, before market open.
The Company will host a corresponding conference call and live
webcast to discuss the financial results and key topics including
business strategy, partnerships and regulatory and reimbursement
processes, at 8:30 a.m. (ET) / 1:30 p.m. (BST).
Conference Call Details:To
participate in the live conference call via telephone, please
register here. Upon registering, a dial-in number and unique
PIN will be provided in order for interested parties to join the
conference call.
Webcast Registration
link: https://edge.media-server.com/mmc/p/y9qtsbmx
About RenalytixRenalytix (LSE:
RENX) (NASDAQ: RNLX) is the global founder and leader in the new
field of bioprognosis™ for kidney health. The company has
engineered a new solution that enables early-stage chronic kidney
disease progression risk assessment. The Company’s lead product,
KidneyIntelX™, has been granted Breakthrough Designation by the
U.S. Food and Drug Administration and is designed to help make
significant improvements in kidney disease prognosis, transplant
management, clinical care, patient stratification for drug clinical
trials, and drug target discovery
(visit www.kidneyintelx.com). For more information,
visit www.renalytix.com.
For further information, please contact:
Renalytix plc |
www.renalytix.com |
James McCullough,
CEO |
Via Walbrook PR |
|
|
Stifel (Nominated Adviser, Joint Broker) |
Tel: 020 7710 7600 |
Alex Price / Nicholas
Moore |
|
|
|
Investec Bank plc (Joint Broker) |
Tel: 020 7597 4000 |
Gary Clarence /
Daniel Adams |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780
or renalytix@walbrookpr.com |
Paul McManus / Lianne
Applegarth / Alice Woodings |
Mob: 07980 541 893 / 07584 391 303 / 07407 804 654 |
|
|
CapComm Partners |
|
Peter DeNardo |
Tel: 415-389-6400 or investors@renalytix.com |
Renalytix (NASDAQ:RNLX)
Historical Stock Chart
From Apr 2024 to May 2024
Renalytix (NASDAQ:RNLX)
Historical Stock Chart
From May 2023 to May 2024